news FORESIGHT consortium secures €9 million to fast-track drug development 24 February 2025 | By Drug Target Review The FORESIGHT consortium has secured €9 million to speed up drug development using advanced molecular imaging, targeting major diseases like cancer, autoimmune conditions, and heart disorders.